COMMUNIQUÉS West-GlobeNewswire
-
Sonnet BioTherapeutics Announces $3.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
09/12/2024 -
Organic & Natural Health Association’s 10th Annual Conference Explores Sustainability From an International Perspective
09/12/2024 -
EUROAPI moves into a new chapter with new Governance and Leadership
09/12/2024 -
EUROAPI entame un nouveau chapitre avec une nouvelle gouvernance et un nouveau management
09/12/2024 -
Press Release: ASH: Sarclisa combinations demonstrated significant benefits in newly diagnosed multiple myeloma patients
09/12/2024 -
Communiqué de presse : ASH : les associations thérapeutiques avec Sarclisa procurent des bénéfices significatifs aux patients atteints d’un myélome multiple nouvellement diagnostiqué
09/12/2024 -
iPack Rx Unit Dose Packaging System Achieves CE Certification, Enhancing Medication Safety and Efficiency
09/12/2024 -
Affimed Reports Promising Phase 1 Efficacy and Safety Data for AFM28 in Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
09/12/2024 -
Health-ISAC Bestows Newly Renamed Steve Katz Hero Award
09/12/2024 -
Tessera Therapeutics Highlights Advances Across In Vivo Programs for Sickle Cell Disease and T-Cell Therapies at the 66th American Society of Hematology Annual Meeting
09/12/2024 -
Disc Medicine Presents Positive Clinical and Translational Data Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting
09/12/2024 -
Two Data Analyses from Clinical Trials Show Epcoritamab (DuoBody® CD3xCD20) Induces Durable, Complete Responses as Monotherapy and Combination Treatment in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
09/12/2024 -
Aptose Clinical Data Featured in Poster Presentation at the 2024 ASH Annual Meeting Support Tuspetinib Triple Drug Therapy for Newly Diagnosed AML
09/12/2024 -
CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting
09/12/2024 -
Editas Medicine Reports Updated Clinical Data from the RUBY Trial of Reni-cel in Patients with Severe Sickle Cell Disease at the American Society of Hematology (ASH) Annual Meeting
09/12/2024 -
Ipsen - November 2024 - Monthly information relative to the total number of voting rights and shares composing the share capital
09/12/2024 -
Ipsen - Novembre 2024 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
09/12/2024 -
Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences’ Scientific Advisory Board
09/12/2024 -
Novo Nordisk A/S - share repurchase programme
09/12/2024
Pages